In an Interview with CEOCFO Magazine, CEO Dr. Carl Schwartz Explains how the Company’s Database of Tumors, Artificial Intelligence Technology, and Groundbreaking Method for Growing Human Cancer Cells Makes it a Leader in Personalized Medicine EAGAN, MN / ACCESSWIRE / July 17, 2018 / CEOCFO Magazine, an independent investment publication that highlights important technologies and companies, today released an interview with Dr. Carl Schwartz, President, CEO and Director of Precision Therapeutics Inc (NASDAQ: AIPT). As Dr. Schwartz told CEOCFO’s Bud Wayne, Precision Therapeutics has becomeRead more
- Cannabis Strategic Ventures and Sunniva Inc. Enter Into Cannabis Extraction Services Agreement
- Precision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment Strategies
- Precision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal System
- PHI Group Partners with Fintech Green Investment Company
- Third and Fourth Quarters 2018 Expected to See Continued Advancements for the Pura Natural’s Grease Beast Products Amid Approval as an Available Vendor to All True Value and Ace Hardware Stores
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More